Question 1

How many shares of SGMO does JACOBS LEVY EQUITY MANAGEMENT, INC own?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of SGMO (SANGAMO THERAPEUTICS INC) before exiting the position in 2026-Q2.

Question 2

What is JACOBS LEVY EQUITY MANAGEMENT, INC's SGMO position worth?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC's SGMO position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is JACOBS LEVY EQUITY MANAGEMENT, INC buying or selling SGMO?

Accepted Answer

In 2026-Q2, JACOBS LEVY EQUITY MANAGEMENT, INC exited their SGMO position entirely (-100.0% change in shares).

Question 4

When did JACOBS LEVY EQUITY MANAGEMENT, INC first buy SGMO?

Accepted Answer

Based on available 13F filings, JACOBS LEVY EQUITY MANAGEMENT, INC first reported a position in SGMO in 2024-Q3. They have held the position across 17 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$0.14	0
2026-Q1	Increased	2.1M	+95.1%	$506,240	0.0%	$0.39	38
2025-Q4	Increased	1.1M	+24.1%	$441,300	0.0%	$0.43	29
2025-Q3	Unchanged	846,533	0.0%	$570,055	0.0%	$0.70	0
2025-Q2	Decreased	846,533	-34.8%	$458,228	0.0%	$0.54	0
2025-Q1	Increased	1.3M	+74.8%	$851,087	0.0%	$0.82	37
2024-Q4	Decreased	742,462	-49.5%	$757,311	0.0%	$2.34	0
2024-Q3	Decreased	1.5M	-50.1%	$1.3M	0.0%	$0.87	0